GÜMÜŞLÜ, S. 2012. Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma. 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , (Geneva, Switzerland), 179.

GÜMÜŞLÜ, S., (2012). Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma . 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) (pp.179). Geneva, Switzerland

GÜMÜŞLÜ, SAADET. "Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma," 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Geneva, Switzerland, 2012

GÜMÜŞLÜ, SAADET. "Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, pp.179, 2012

GÜMÜŞLÜ, S. (2012) . "Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma." 31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI) , Geneva, Switzerland, p.179.

@conferencepaper{conferencepaper, author={SAADET GÜMÜŞLÜ}, title={Omalizumab affects systemic levels of ceruloplasmin oxidase activity in severe allergic asthma}, congress name={31st Congress of the European Academy of Allergy and Clinical Immunology (EAACI)}, city={Geneva}, country={Switzerland}, year={2012}, pages={179} }